相关实验视频

Updated: Jun 8, 2026

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

14.2K

对高级软组织肉瘤的全身疗法试验的临床益处和脆弱性评估

Dina Braik1, Christopher Lemieux2, Brooke E Wilson3

  • 1Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.

Cancer
|September 18, 2024
PubMed
概括

根据欧洲医学瘤学会临床益处量表 (MCBS) 的数据,大多数软组织肉瘤 (STS) 治疗方法缺乏实质性的临床益处. 积极的试验结果往往很脆弱,表明需要更强大的终点和现实世界的验证.

关键词:
在ESMO-MCBS中,我们可以看到.先进的或转移性的.临床益处 临床益处 临床益处脆弱性是一种脆弱性.软组织肉瘤软组织肉瘤系统性治疗是一种全身疗法.

更多相关视频

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

9.5K
Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone06:53

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

2.7K

相关概念视频

Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...